Representative before the EPO

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1288.54
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Company dna finnegan europe llp
operating since 2013
Headquarter in London and 1 office
active in Legal Services

We have observed 13 EP applications Hazel Ford has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 8, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11749881

TREATMENT OF LIVER CANCER

IPC classification:
A61P 35/00, G01N 33/50, A61K 31/47, A61K 31/4706, A61K 31/7088
Agent:
Hazel Ford, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11748700

TREATMENT

IPC classification:
A61P 1/16, A61K 31/00, A61K 31/417, A61K 31/4178, A61K 31/475
Applicant:
UCL Business plc
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12774207

USE OF MYELIN BASIC PROTEIN AS A NOVEL GENETIC FACTOR FOR RHEUMATOID ARTHRITIS

IPC classification:
C12N 15/09, C12Q 1/68, G01N 33/15, G01N 33/50, G01N 33/53, G01N 33/564
Applicant:
Kyoto University
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP12792838

GENE TARGETING VECTOR, METHOD FOR MANUFACTURING SAME, AND METHOD FOR USING SAME

IPC classification:
C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09
Applicant:
Yokohama City University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12792225

PRODUCTION METHOD FOR ARTIFICIAL CANCER STEM CELL AND INDUCED DIFFERENTIATION METHOD THEREFOR

IPC classification:
C12N 5/10, C12N 15/09, C12Q 1/02
Applicant:
Yokohama City University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12752901

NOVEL VITAMIN D RECEPTOR MODULATOR WITH PARTIAL AGONIST ACTIVITY

IPC classification:
A61P 3/10, A61P 9/00, A61P 17/06, A61P 19/10, A61P 25/28, A61P 31/00, A61P 35/00, A61P 37/06, A61P 43/00, C07C 401/00, A61K 31/59
Applicant:
Nihon University
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP13195156

Reagents and Methods for PCR

IPC classification:
C12Q 1/68
Applicant:
Brandeis University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11831546

METHODS OF MAKING L-ORNITHINE PHENYL ACETATE

IPC classification:
A61P 1/16, C07C 57/46, C07C 227/18, C07C 229/26, A61K 31/192, A61K 31/198
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13195355

Engineered CO2 fixing microorganisms producing carbon-based products of interest

IPC classification:
C12M 1/00, C12M 3/00
Agent:
Multiple attorneys, J A Kemp
Agent:
Hazel Ford, Finnegan Europe LLP
Status:
EXAMINATION IN PROGRESS
EP12813711

E-SELECTIN ANTAGONIST COMPOUNDS, COMPOSITIONS, AND METHODS OF USE

IPC classification:
A61P 35/00, C07H 15/207, A61K 31/7034
Agent:
Hazel Ford, Finnegan Europe LLP
Status:
GRANT OF PATENT INTENDED
EP12818038

TECHNIQUE FOR CLEAVING OUT PART OF poly(A) CHAIN AND/OR 3'-TERMINAL SEQUENCE OF mRNA TO INHIBIT TRANSLATION REACTION

IPC classification:
A61P 25/00, A61P 35/00, A61P 37/08, C12N 5/10, C12N 15/09, A01K 67/027, A61K 31/7105, A61K 31/713, A61K 48/00
Applicant:
Tokyo Institute of Technology
Applicant:
Yokohama City University
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION WITHDRAWN
EP11748969

TREATMENT

IPC classification:
A61P 1/16, A61P 13/12, A61K 31/00, A61K 38/04
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11825257

MODEL ANIMAL FOR STUDYING HAIR GROWTH CYCLE

IPC classification:
C12N 15/09, G01N 33/50, A01K 67/027
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Multiple attorneys, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature